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Background: Lupin proteins exert hypocholesterolemic effects in man and animals, although the underlying
mechanism remains uncertain. Herein we investigated whether lupin proteins compared to casein modulate sterol
excretion and mRNA expression of intestinal sterol transporters by use of pigs as an animal model with similar lipid
metabolism as humans, and cellular cholesterol-uptake by Caco-2 cells.
Methods: Two groups of pigs were fed cholesterol-containing diets with either 230 g/kg of lupin protein isolate
from L. angustifolius or 230 g/kg casein, for 4 weeks. Faeces were collected quantitatively over a 5 d period for
analysis of neutral sterols and bile acids by gas chromatographically methods. The mRNA abundances of intestinal
lipid transporters were analysed by real-time RT-PCR. Cholesterol-uptake studies were performed with Caco-2 cells that
were incubated with lupin conglutin γ, phytate, ezetimibe or albumin in the presence of labelled [4-14C]-cholesterol.
Results: Pigs fed the lupin protein isolate revealed lower cholesterol concentrations in total plasma, LDL and HDL
than pigs fed casein (P < 0.05). Analysis of faeces revealed a higher output of cholesterol in pigs that were fed lupin
protein isolate compared to pigs that received casein (+57.1%; P < 0.05). Relative mRNA concentrations of intestinal
sterol transporters involved in cholesterol absorption (Niemann-Pick C1-like 1, scavenger receptor class B, type 1)
were lower in pigs fed lupin protein isolate than in those who received casein (P < 0.05). In vitro data showed that
phytate was capable of reducing the uptake of labelled [4-14C]-cholesterol into the Caco-2 cells to the same extend
as ezetimibe when compared to control (−20.5% vs. −21.1%; P < 0.05).
Conclusions: Data reveal that the cholesterol-lowering effect of lupin protein isolate is attributable to an increased
faecal output of cholesterol and a reduced intestinal uptake of cholesterol. The findings indicate phytate as a
possible biofunctional ingredient of lupin protein isolate.
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Caco-2 cellsBackground
Diets that contain lupin proteins have repeatedly been
shown to lower plasma cholesterol concentrations in hy-
percholesterolemic rats [1-3] and humans [4] compared
to casein. Those studies demonstrated higher protein con-
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stated.(LDL) receptor, and a transcriptional up-regulation of
hepatic cholesterol 7α-hydroxylase (CYP7A1), a key en-
zyme involved in the synthesis of bile acids, in response to
lupin proteins [1-3]. However, the mechanism by which
ingested lupin proteins can alter hepatic LDL receptor
and hepatic enzyme expression remains uncertain. It may
be argued whether the observed alterations in liver lipid
metabolism can be attributed to intact lupin polypeptides
that enter the organism. However, it appears more plaus-
ible that lupin proteins and/or lupin protein-associated
compounds, respectively, exert their physiological effectsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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protein and mRNA concentrations of LDL receptor and
CYP7A1. As a matter of facts, recent data demonstrate
that pigs fed a diet with blue lupin seeds had lower plasma
cholesterol concentrations and a higher faecal output of
neutral sterols than casein fed pigs [5]. Those authors as-
sumed that the hypocholesterolemic effect of the blue lu-
pin seeds, which were added to the diet as substitute for
corn starch, soybean oil and casein, was attributable to im-
paired intestinal cholesterol absorption. However, whole
lupin seeds contain not only proteins but also fibres that
may have caused the increased sterol output in that study.
Whether isolated lupin proteins themselves could contrib-
ute to the increased cholesterol excretion has not been
demonstrated yet, though there is evidence suggesting that
proteins cause these kind of effects. Ovariectomised cyno-
molgus monkeys that were fed isolated soybean proteins
for 20 weeks absorbed less cholesterol in the intestine
than monkeys which received casein alone or supple-
mented with soy isoflavones [6]. In that study soybean
proteins revealed a specific impact on cholesterol output,
whilst the excretion of bile acids was not influenced in re-
sponse to soybean proteins. In view of the considerable
genetic similarity between soy and lupin, it is most likely
that the cholesterol-lowering effect of lupin proteins is
also caused by an increased sterol output.
The current study aimed to examine the effect of lupin
protein isolate compared to casein on faecal output of
neutral and acidic sterols, and on the expression of in-
testinal sterol transporters. Pigs were used as an animal
model because morphology and physiology of the
gastrointestinal system, the ingesta transit times, the di-
gestive efficiencies and the response to hyperlipidemic
diets are comparable to those of humans [7]. Since lupin
proteins have been shown to be most effective in lower-
ing plasma cholesterol concentrations when adminis-
tered together with a hypercholesterolemic diet [2], all
pigs received a cholesterol-containing diet. Besides pa-
rameters that enable conclusions on intestinal sterol ab-
sorption, the bioavailability of minerals and fat-soluble
vitamins were analysed.
Since in vitro experiments with a buckwheat protein
product [8] and soy protein hydrolysate [9] showed re-
duced cholesterol-uptake by Caco-2 cells compared to
control, similar experiments were conducted to investi-
gate which component of the lupin protein isolate is re-
sponsible for the lipid lowering effect. To this aim,
Caco-2 cells were incubated with pure conglutin γ, a
candidate cholesterol-lowering lupin seed protein in
force of its ability to reduce the LDL receptor activity in
HepG2 cells [1], and phytate, which naturally occurs in
isolates of plant proteins like lupin proteins. Incubations
were performed in the presence of radiolabelled [4-14C]-
cholesterol to quantify the cholesterol-uptake.Methods
Animals, diet and design
Twenty-four 12 weeks old female crossbred pigs [(German
Landrace × Large White) x Pietrain] with an initial body
weight of 34.9 ± 1.9 kg (mean ± SD) were randomly
assigned to 2 groups of 12 pigs each. The animals received
a hypercholesterolemic basal diet, one group with 230 g/kg
lupin protein isolate from L. angustifolius and the other
group (control) with 230 g/kg casein (Meggle, Wasserburg,
Germany). The diets were fed for 4 weeks. Besides the ex-
perimental proteins, the hypercholesterolemic basal diet
contained (in g/kg diet) wheat (400), corn starch (casein
diet: 197; lupin protein diet: 192), coconut fat (120),
cholesterol (20), vitamin and mineral mixture (20) and
monocalcium phosphate (13). The lupin protein diet
was supplemented additionally with 5 g/kg of DL-
methionine at the expense of corn starch to meet the re-
quirement for methionine for growing pigs [10]. Minerals
and vitamins were added according to the recommenda-
tions of the NRC [10] as precast mix (Mineral feed, Basu,
Bad Sulza, Germany). The diets were calculated on the
basis of GfE recommendations [11] to contain 15 MJ/kg.
The pigs were individually kept in pens in an environmen-
tally controlled facility with a temperature of 20°C, relative
humidity between 55-60%, and light from 06:00 am to
06:00 pm. All pigs had free access to food. Water was
available ad libitum from a nipple drinker system during
the whole experiment. The pigs were weighed once a
week. During the last 5 days of the experiment, six pigs of
each group were kept in metabolism cages which allowed
a quantitative collection of faeces. The experimental pro-
cedure was performed according to the established guide-
lines for care and handling of laboratory animals and was
approved by the council of Saxony-Anhalt, Germany (No.
42502-2-1040MLU).Preparation and characterisation of the experimental
proteins
Casein that was used as control protein was not further
processed. Defatted total protein isolate of L. angustifo-
lius was provided by the Fraunhofer Institute (IVV,
Freising, Germany). The crude protein content of the
diet proteins was determined by official methods [12],
and was 948 g/kg dry matter (DM) for casein and 915 g/kg
DM for lupin protein isolate. The amino acid composition
of the experimental proteins is shown in Additional file 1.
Casein contained (in g/kg DM) 0.58 calcium, 2.7 phos-
phorus, 0.10 magnesium, and 0.056 zinc. The lupin pro-
tein isolate contained (in g/kg DM) 1.02 calcium, 9.41
phosphorus, 0.59 magnesium, and 0.032 zinc. The calcu-
lated amount of phytic acid based on the analysed phytate
phosphate in the lupin protein isolate was 25.4 g/kg DM.
No detectable phytate phosphate was found in casein.
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according to Lovati et al. [13]. The procedure consisted
of various chromatographic steps, including metal affinity
chromatography on NiNTA-agarose. The homogeneity of
purified conglutin γ was assessed by SDS-PAGE [13].
Amino acid analysis of the experimental proteins
Samples were oxidised and then hydrolysed with 6 M
HCl [12] to determine the amino acid concentrations.
Separation and quantification of the amino acids were
performed by ion-exchange chromatography following
post-column derivatisation in an amino acid analyzer
(Biotronic LC 3000; Eppendorf, Hamburg, Germany).
After digesting the diets with barium hydroxide [14]
tryptophan was quantified by reversed-phase HPLC [15].
Analysis of phytate phosphate and phytic acid of the
experimental proteins
The concentration of phytate phosphate in the dietary
proteins was analysed by a method of Harland and Oberleas
[16]. Briefly, phytic acid was extracted from 2 g protein
with 40 ml 2.4% HCl. Afterwards the samples were filtered
and immobilised onto an anion exchange column (AG1-
X4, 100–200 mesh, chloride form, Bio-Rad Laboratories,
Hercules, California, USA). After washings the retained
inositol phosphates were eluted from the column with
0.7 M NaCl. A 50 μl aliquot of the eluent was hydrolysed
with 50 μl of a 5 M HClO4 and 1 M H2SO4 mixture, and
was ashed at 250°C. The inorganic phosphate concentra-
tion of the samples was quantified colourimetrically by
use of standards. The phytic acid content of the sample
was calculated to be 28.2% × phosphorus [16].
Sample collection
Blood samples that were taken from each animal at the
beginning and at the end of the experiment were col-
lected in heparinised tubes and centrifuged at 4°C and
1,100 g for 10 min to obtain plasma. Faeces were col-
lected twice a day over a period of 5 days. Pooled faeces
from each pig were frozen at −20°C pending analysis. At
the end of the experimental period, the pigs were anaes-
thetised and killed by exsanguination 12 h after their last
meal. The liver was harvested and weighed. Thirty cm of
small intestine (10 cm before and 20 cm behind the pa-
pilla duodeni major) were removed, rinsed with physio-
logical NaCl solution and cut lengthwise. The intestinal
mucosa was scraped and mixed. Samples of liver and in-
testinal mucosa were snap-frozen in liquid nitrogen and
stored at −80°C pending further analysis.
Lipoprotein isolation and lipid analysis
Plasma lipoproteins were separated according to their
density (very low density lipoprotein, VLDL, ρ < 1.006 g/ml;
LDL, 1.006 g/ml < ρ < 1.040 g/ml; high density lipoprotein,HDL, 1.063 g/ml < ρ < 1.21 g/ml) by step wise ultracentri-
fugation. Lipids from liver and freeze dried faeces were ex-
tracted with a mixture of n-hexane and isopropanol (3:2, v/v)
according to the method from Hara & Radin [17] modi-
fied by Eder & Kirchgessner [18]. To measure lipid con-
centrations of liver and faeces, aliquots of the lipid
extracts were dried and residues dissolved in a mixture of
Triton X-100 and chloroform (1:1, w/w). The cholesterol
and triglyceride concentrations of plasma, plasma lipopro-
teins, liver and faeces were determined using enzymatic
reagent kits (Diagnostic Systems, Holzheim, Germany).
Analysis of faecal neutral sterols and bile acids by GC-FID
and GC-MS
Lyophilised aliquots of homogenised faeces were ana-
lysed for neutral sterols (cholesterol, coprostanol, choles-
tanol, coprostanone and cholestanone) and for bile acids
(iso-lithocholic acid, lithocholic acid, chenodeoxycholic
acid, hyodeoxycholic acid, hyocholic acid) according to
gas chromatographically methods, which have been pre-
viously described [19,20]. In brief, 50 mg faeces were
provided with 5α-cholestane (Sigma-Aldrich, Taufkirchen,
Germany) as internal standard and underwent a mild alka-
line hydrolysis with freshly prepared 1 M ethanolic NaOH.
Free sterols were extracted with cyclohexane, extracts
were dried under nitrogen stream and residues were re-
solved in decane. The analysis was performed using GC-
FID (GC17A-AF Vers. 3, Shimadzu Corp., Kyoto, Japan).
After extraction of the neutral sterols the samples under-
went a strong alkaline hydrolysis with 10 M NaOH solu-
tion. The samples were than adjusted to pH 1 with HCl
and free bile acids were extracted with diethyl ether. Nor-
cholic acid (Sigma-Aldrich) was added as internal stand-
ard and extracts were methylated, silylated and finally
dried under nitrogen stream. Residues were resolved in
decane and injected in the GC-MS (GC17-QP5000,
Shimadzu Corp.). Bile acid quantification was based on
the multi-ion detection with m/z = 253.20 for norcholic
acid, m/z = 215.25 for iso-lithocholic acid and lithocholic
acid, m/z = 73.10 for chenodeoxycholic acid, m/z = 255.3
for hyodeoxycholic acid, and m/z = 458.50 for hyocholic
acid.
RNA isolation and real-time RT-PCR
For the determination of mRNA abundances total RNA
was isolated from intestinal mucosa using Trizol™ re-
agent (Invitrogen, Karlsruhe, Germany) according to the
manufacturer’s protocol. The RNA concentration was
estimated from the optical density at 260 nm. RNA pur-
ity was proofed by agarose gel electrophoresis. A total of
1.2 μg of total RNA was used for cDNA synthesis using
the RevertAid™ M-MuLV Reverse transcriptase (Thermo
Fisher Scientific Inc., Waltham, MA, USA). For the de-
termination of relative mRNA concentrations real-time
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(Corbett Research, Mortlake, Australia) was applied. A
total of 1 μl cDNA templates were amplified in a total
volume of 20 μl using 200 μM dNTPs (Genecraft, Co-
logne, Germany), 1.5 mM MgCl2, 0.5 U GoTaq DNA
polymerase, 4 μl 5× buffer (all from Promega, Mannheim,
Germany), 0.2 μl 10× SYBR Green (Sigma-Aldrich), and
5.4 pM of each primer. The PCR protocol provided an ini-
tial denaturation at 95°C for 3 min and 20–35 cycles of
amplification comprising denaturation at 95°C for 25 s,
annealing at primer-specific temperatures (57-60°C) for
30 s and elongation at 72°C for 55 s. Subsequently mel-
ting curve analysis was performed from 50°C to 99°C
with continuous fluorescence measurement. The ampli-
fication of a single product of the expected size was con-
firmed using 2% agarose gel electrophoresis. Relative
mRNA concentrations were calculated using the ΔΔCt
method [21]. Ct-values of target genes and the reference
genes were obtained using Rotorgene Software 5.0. Suc-
cinate dehydrogenase, subunit A (SDHA) and ribosomal
protein S9 (RPS9) served as appropriate reference genes.
Relative mRNA expression was expressed as fold change
of mRNA abundance relative to the casein group. Se-
quences of the gene-specific primers are shown in
Additional file 2.Plasma concentrations of 25-hydroxy vitamin D3 (25(OH)
D3) and tocopherols
The plasma concentration of 25(OH)D3 was determined
by coupled liquid chromatography-mass spectrometry
(LC-MS) using a MassChrom™ reagent kit (Chromsys-
tems, Munich, Germany) as described recently [22]. In
brief, plasma samples were mixed with deuterated 25
(OH)D3 (Chemaphor Inc., Ottawa, Canada) as internal
standard. Precipitation reagent was added, and subsequent
to centrifugation at 15,000 g for 5 min the supernatant
was transferred into a HPLC vial and analysed by HPLC
(Agilent 1100 HPLC, Agilent Technologies, Waldbronn,
Germany), coupled to a MS system (API 2000, Applied
Biosystems, Darmstadt, Germany).
The concentration of plasma tocopherol isomers was
determined by HPLC analysis [23]. Plasma samples were
mixed with 1 ml of a 0.1 g/l pyrogallol solution (ethanol,
absolute) and 150 μl saturated NaOH solution. This mix-
ture was incubated at 70°C for 30 min, and tocopherols
were extracted with n-hexane. Individual tocopherols of
the extracts were separated isocratically by HPLC (Agilent
1100 HPLC, Agilent Technologies) using a mixture of n-
hexane and 1,4 dioxane (94:6, v/v) as mobile phase and a
LiChrospher Si-60 column (5 μm particle size, 250 mm
length, 4 mm internal diameter; Agilent Technologies)
and detected by fluorescence (excitation wavelength
295 nm, emission wavelength 325 nm).Analysis of plasma and faeces minerals
For the determination of calcium, phosphorus, magne-
sium and zinc concentrations, plasma was diluted with
distilled water and faeces were hydrolysed with 6 M HCl
and 1.76 M HNO3 according to the official VDLUFA
method [12]. The minerals were analysed by inductively
coupled plasma optical emission spectroscopy (ICP OES;
Varian 715-ES; Agilent Technologies) using selected wave-
lengths (Ca: 318 nm, P: 215 nm, Mg: 280 nm, Zn: 214 nm).
Analyses were run in duplicates.
Cell culture experiments
Caco-2 cells were cultured in minimal essential medium
(MEM) with 10% fetal bovine serum (FBS) at 37°C with
5% CO2 and passaged at 90% of confluence [24]. For
cholesterol-uptake experiments, cells were seeded in
common 6 well plates at a density of 0.8 × 106 cells per
well and cultured for 20 to 23 days. Cells were used for
experiments from passage 17 to 27. 24 h prior to the ex-
periments cells received serum free medium.
For the cholesterol-uptake, cells were incubated for
2 h at 37°C with 2 mM radioisotopically labelled choles-
terol ([4-14C]-cholesterol, 0.1 mCi/ml, American Radi-
olabeled Chemicals Inc., St. Louis, MO, USA) dissolved
in MEM plus 2% FBS as previously described [25,26]
with or without the following test substances: 0.04 mg/ml
ezetimibe (Santa Cruz Biotechnology Inc., Heidelberg,
Germany), 5 mg/ml albumin (Sigma-Aldrich), 0.6 mg/ml
lupin conglutin γ or 0.18 mg/ml sodium phytate (Sigma-
Aldrich). The ezetimibe concentration which we used for
the incubation study ranged in the upper concentration
levels of ezetimibe used in other cell culture experiments
[27,28]. Prior to the incubation, the cells were washed
twice with HEPES buffer (25 mM HEPES/Tris (pH 7.5),
140 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.8 mM
MgSO4, 5 mM glucose, 37°C). After the incubation, the
cells were quickly washed twice with phosphate buffered
saline (37°C) containing 1% bovine serum albumin and
four times with ice-cold HEPES buffer. Finally, cells were
dissolved in radioimmunoprecipitation assay (RIPA) buffer
(50 mM Tris/HCl (pH 8.0), 150 mM NaCl, 1% Triton X-
100 (w/v), 0.5% sodium deoxycholate (w/v), 0.1% sodium
dodecyl sulfate (w/v)) and the amount of absorbed radi-
olabelled cholesterol was determined by liquid scintillation
spectrometry (Liquid Scintillation Analyser Tri-Carb 2800
TR, Perkin Elmer, Rodgau, Germany). Protein concentra-
tion was measured using BC assay (Uptima, Interchim,
Montlucon, France). Data are expressed as pmol of chol-
esterol per mg of cell protein.
Statistical analysis
Values are expressed as means ± SD. Means of the two
groups were compared by Student’s t-test using the statistic
software MINITAB (Release 13, Minitab Ltd., Michigan,
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final means were tested by the paired t-test. Means were
considered significantly different at P < 0.05.
Results
Daily food intake and final body mass of pigs
Daily food intake (casein group: 1.22 ± 0.04 kg/d; lupin
protein group: 1.23 ± 0.03 kg/d) and final body mass (casein
group: 49.0 ± 3.0 kg; lupin protein group: 48.8 ± 2.4 kg) did
not differ between the two groups of pigs.
Plasma and liver lipids
At baseline, the concentration of cholesterol in plasma
and lipoproteins was not different between the two
groups of pigs (Figure 1A). Pigs treated with the hyper-
cholesterolemic diet for 4 weeks developed significantly
higher cholesterol concentrations in plasma, LDL and
HDL compared to baseline (Figure 1A; P < 0.05), but
pigs that were fed the lupin protein isolate had lower0
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Figure 1 Cholesterol (A) and triglyceride (B) concentrations in
plasma and lipoproteins of pigs fed the experimental diets.
Samples were analysed before (basal) and after (final) feeding diets
containing 23% casein or 23% lupin protein isolate for 4 weeks.
Values are means (n = 12) with standard deviations. *Significantly
different between the two groups at one time point (Student’s t-test,
P < 0.05). #Significantly different between basal and final means
within one group (P < 0.05, paired t-test).final concentrations of plasma, LDL and HDL choles-
terol (−32.6%; −28.9% and −16.5%; P < 0.05) than pigs
fed casein (Figure 1A). The ratios of total to HDL chol-
esterol (casein group 2.83 ± 0.73 vs. lupin protein group
2.46 ± 0.38) and LDL to HDL cholesterol (casein group
1.15 ± 0.36 vs. lupin protein group 1.13 ± 0.25) did not
differ between the two groups. Compared to baseline,
the final concentration of triglycerides in plasma in-
creased slightly in the lupin protein group (P < 0.05) but
not in the casein group. The concentration of VLDL tri-
glycerides increased in both groups of pigs (casein group,
P < 0.01; lupin protein group, P < 0.01), without showing
any differences in the final concentrations of VLDL tri-
glycerides between the two groups (Figure 1B). Contents
of liver cholesterol (casein group: 9.56 ± 4.10 μmol/g; lu-
pin protein group: 8.50 ± 2.32 μmol/g) and liver triglycer-
ides (casein group: 7.35 ± 0.97 μmol/g; lupin protein
group: 6.76 ± 1.62 μmol/g) did not differ between the two
groups of pigs.
Faecal excretion of triglycerides, neutral sterols
and bile acids
Analysis of faeces revealed a higher cholesterol excretion
in pigs that were fed the lupin protein isolate than in pigs
receiving casein (+ 57.1%; P < 0.05; Figure 2A). The faecal
excretion of coprostanol, cholestanol, cholestanone, cop-
rostanone, and bile acid derivatives did not differ between
the two groups of pigs (Figure 2A,B,C and D). Lupin protein
isolate also did not influence the faecal output of triglycer-
ides compared to casein (casein group: 0.68 ± 0.27 g/d; lu-
pin protein group: 0.65 ± 0.44 g/d).
Relative mRNA concentrations of intestinal sterol
transporters and receptors
Relative mRNA abundances of the intestinal transporters
Niemann-Pick C1-like 1 (NPC1L1) and scavenger recep-
tor class B, type 1 (SR-BI), which are involved in the trans-
port of cholesterol from the intestinal lumen into the
intestinal epithelial cells, were significantly lower in the
lupin protein isolate fed pigs than in the casein fed pigs
(P < 0.05, Figure 3). The relative mRNA concentrations
of fatty acid translocase/Cluster determinant 36 (FAT/
CD36), which is involved in cholesterol absorption, the
ATP-binding cassette transporter (ABC) G8 which cataly-
ses the reverse cholesterol transport and the basolateral
cholesterol transporter ABCA1 tended to be lower in the
lupin protein group than in the casein group (P = 0.05,
P = 0.06 and P = 0.08, respectively; Figure 3). The rela-
tive mRNA concentration of ABCG5 did not differ sig-
nificantly between the two treatment groups (Figure 3).
The relative mRNA concentration of the farnesoid X re-
ceptor (FXR), a transcription factor which is activated
by bile acids was significantly lower in the lupin protein
group compared to the casein group (P < 0.05, Figure 3).
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Figure 2 Daily faecal output of neutral sterols and bile acids of pigs fed the experimental diets. Pigs received diets containing 23% casein
or 23% lupin protein isolate for 4 weeks. (A) major neutral sterols cholesterol and coprostanol, and total neutral sterols; (B) minor neutral sterols
cholestanol, cholestanone and coprostanone; (C) major bile acids lithocholic acid and hyodeoxycholic acid, and total bile acids; (D) minor bile
acids chenodeoxycholic acid, iso- lithocholic acid and hyocholic acid. Faeces were collected quantitatively during the last 5 days of the experi-
ment. Major and minor neutral sterols were analysed by GC-FID, major and minor bile acids were analysed by GC-MS. Values are means (n = 6)
with standard deviations. *Significantly different from the casein group (P < 0.05, Student’s t-test).
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mRNA of the liver X receptor alpha (LXRα) (P = 0.09;
Figure 3) compared to the casein fed animals. There
was no difference in ApoA1 mRNA expression between
the two groups.
Plasma 25-hydroxy vitamin D3 and plasma tocopherol
Plasma concentrations of 25(OH)D3 at the beginning and
at the end of the experiment did not differ between the two
groups of pigs. Considering the changes of plasma 25(OH)
D3 within the experimental period, lupin protein isolate fed
pigs revealed a stronger reduction of the plasma concentra-
tion than casein fed pigs (Figure 4A). Tocopherol isomer
analysis revealed no detectable concentrations of thetocopherols β, γ and δ in plasma. In pigs fed casein, final
plasma concentration of tocopherol α was higher than at
the beginning of the experiment (P < 0.05), whereas such
an increase of tocopherol α concentration within the ex-
perimental period was not observed in lupin protein isolate
fed pigs (Figure 4B). Comparing the changes of plasma toc-
opherol α concentration within the 4 weeks of treatment,
increase of circulating tocopherol α tended to be lower in
the lupin protein group than in the casein group (Figure 4B).
Plasma mineral concentrations and faecal output of
minerals
Basal plasma concentrations of total phosphorus, cal-
cium, magnesium and zinc did not differ between the
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Figure 3 Relative mRNA concentrations of sterol transporters and receptors in intestinal mucosa of pigs fed the experimental diets.
Pigs received diets containing 23% casein or 23% lupin protein isolate for 4 weeks. Niemann-Pick C1-like 1 (NPC1L1), fatty acid translocase/Cluster
determinant 36 (FAT/CD36), scavenger receptor class B, type 1 (SR-BI), ATP-binding cassette transporters (ABC) A1, G5, and G8, apolipoprotein A-I
(ApoA1), farnesoid X receptor (FXR), and liver X receptor (LXR) α. Values are means (n = 12) with standard deviations. The mRNA concentrations of
succinate dehydrogenase, subunit A (SDHA) and ribosomal protein S9 (RPS9) were used for normalization. The mRNA concentrations of the genes
are shown relative to those of pigs fed the casein diet (= 1.00). *Significantly different from the casein group (P < 0.05, Student’s t-test).
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Figure 4 Plasma concentrations of 25-hydroxy vitamin D3 (A)
and α-tocopherol (B) of pigs fed experimental diets. Samples
were analysed before (basal) and after (final) feeding diets
containing 23% casein or 23% lupin protein isolate for 4 weeks.
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http://www.nutritionandmetabolism.com/content/11/1/9two groups of pigs (Figure 5A,C and D). In both treat-
ment groups, circulating concentrations of total phos-
phorus increased within the 4 weeks of the experimental
period, indicating raised concentrations of circulating
phospholipids in response to the hypercholesterolemic
diet. Final concentrations of total phosphorus did not
differ between the two groups of pigs, whereas final
plasma concentrations of calcium and magnesium were
lower in the group that received the lupin protein diet
than in the group fed the casein diet (Figure 5A and C).
Pigs fed the lupin protein isolate revealed lower plasma
concentrations of zinc compared to baseline (P < 0.05,
Figure 5D). Baseline and final concentrations of plasma
zinc did not differ in pigs that received the casein diet.
Faecal output revealed a higher excretion of phosphorus,
calcium and magnesium in pigs fed lupin protein isolate
than in pigs fed casein (Figure 5B and E). Faecal output
of zinc did not differ between the two treatment groups
(Figure 5E).
Cholesterol-uptake by Caco-2 cells
Caco-2 cells treated with the cholesterol-uptake inhibitor
ezetimibe revealed a 20.5% lower uptake of [4-14C]-choles-
terol than the control cells (P < 0.05, Figure 6), confirming
the functioning of the cell model. The amount of choles-
terol taken up by the cells was also decreased in cells that
were treated with phytate (−21.1%, P < 0.05; Figure 6).
Neither conglutin γ nor albumin, which served as control
protein, revealed any influence on cholesterol-uptake
compared to the control.
Discussion
The current study with pigs as a model for human
gastrointestinal and lipid physiology reveals hypocholes-
terolemic effects of lupin protein isolate compared to ca-
sein, and confirms previous findings from lupin protein
studies with hypercholesterolemic rats and humans [2,4].
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Figure 6 [4-14C]-cholesterol-uptake by Caco-2 cells during a
2 h-incubation with ezetimibe, albumin, conglutin γ or phytate.
Cells were cultured for 20–23 days before the uptake experiments.
MEM + 2% bovine serum albumin without supplements served as
control medium. Concentrations of test substances: 0.04 mg/ml ezetimibe,
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Values are means (n = 3–5), with standard deviations. *Significantly
different from control (P < 0.05, Student’s t-test).
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both, the undesirable LDL cholesterol and the favourable
HDL cholesterol, compared to pigs that received casein,
which in turn resulted in comparable ratios of total to
HDL cholesterol and LDL to HDL cholesterol in both
groups of pigs. Considering the fact that those ratios are
much better predictors of risk of heart diseases than
LDL or total cholesterol levels alone, we assume that the
cholesterol-lowering properties of lupin protein isolate
may not be inevitably associated with a risk reduction of
cardiovascular diseases. Faeces analyses from this study
showed that the reduction of circulating plasma choles-
terol concentrations in response to lupin protein isolate
administration was associated with a significant increase
of faecal cholesterol output. We therefore assume that
the increased faecal cholesterol excretion in the lupin
protein group compared to the casein group was –at
least partially– responsible for the reduced concentra-
tions of circulating plasma, LDL and HDL cholesterol in
these pigs. As there are no differences between the two
groups in the relative mRNA abundance of ApoA1,
which is a major protein component of HDL, we assume
that the intestinal ApoA1 expression is not the leading
cause for the observed HDL lowering effects. Data fur-
ther show that the faecal output of bile acids, and also
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which normally arise from the conversion of cholesterol
in the gut by intestinal bacteria [29], was not altered in re-
sponse to the treatment with lupin protein isolate. In this
study we used extremely high amounts of dietary choles-
terol (2%), we may therefore assume that the capacity of
coprostanoligenic bacteria to convert cholesterol to
coprostanol was not high enough for further increase of
the faecal coprostanol content in the lupin protein fed
group.
Different factors could have caused the increased out-
put of faecal cholesterol in the lupin protein group: (1)
lupin protein isolate compared to casein could have af-
fected the cholesterol absorption by modifying sterol
transporter expression in the intestine, (2) lupin protein
isolate could have un-specifically bound sterols in the
gut lumen which in consequence increased cholesterol
output, (3) lupin protein isolate could have contributed
to an increased excretion of cholesterol via the bile, (4)
lupin protein isolate could have influenced formation,
solubility or composition of micelles which in turn af-
fected cholesterol-uptake into the enterocytes or (5) lu-
pin protein isolate could have affected the cholesterol
efflux via modification of basolateral sterol transporter
expression in the intestine. Several intestinal trans-
porters are involved in trafficking cholesterol across the
apical enterocyte membrane such as SR-BI [30], FAT/
CD36 [31], NPC1L1 [32] and ABC transporters [33]. All
of these transporters have been found to be regulated by
transcription [34]. Here we show that lupin protein iso-
late, compared to casein, down-regulated the mRNA
abundances of intestinal sterol transporters, especially
those which catalyse the cholesterol-uptake. This is fur-
ther supported by the fact that lupin protein fed pigs
tended to have lower mRNA expression of the choles-
terol responsive nuclear receptor LXRα and its respon-
sive gene ABCA1 which are indicative of reduced
intracellular cholesterol in the intestinal cells of these
animals. Similar effects on LXRα and ABCA1 expression
were also observed in hyperinsulinemic obese Zucker
rats that were fed with soy protein [35]. Thus, the
mRNA data of the current experiment are indicative of a
lower intestinal cholesterol absorption following intake
of lupin protein isolate, and not of an altered cholesterol
efflux.
There is a growing body of evidence that certain pro-
teins such as those from buckwheat seeds [8], egg white
[36], silk protein sericin [37] and soystatin, a novel pep-
tide derived from soybean protein [38], may influence
the incorporation of cholesterol into micelles. Nagaoka
et al. could show that the soybean protein derived Val-
Ala-Trp-Trp-Met-Tyr peptide, designated soystatin, in-
hibits cholesterol absorption by reducing the micellar
solubility of cholesterol [38]. Lupin is genetically similarto soybean and one can assume that the diminished solu-
bilisation of cholesterol in micelles may also occur in re-
sponse to ingested lupin proteins. Intriguingly, soystatin
arises from glycinin, the soybean 11S globulin, and the lu-
pin homologous protein [UniProt:Q53I54] does contain a
resembling sequence, namely Ile-Pro-Phe-Trp-Met-Tyr
between amino acids 152 and 157. Polar lipids such as
fatty acids are normally well absorbed from emulsions,
and incorporation of polar lipids into mixed micelles is
not necessarily a prerequisite for their absorption [39].
However, the formation of micelles is essential for the ab-
sorption of cholesterol and fat-soluble vitamins, because
those non-polar lipids, which position themselves between
the oil and the micellar phase, must be carried by micelles
to the brush border membrane [40]. Analyses of the plasma
concentrations of 25(OH)D3 and tocopherols indicate nega-
tive impacts of lupin protein isolate on micellar transport
system because changes of plasma concentrations of both
vitamins in response to lupin protein isolate revealed a
trend toward lower values compared to casein. On the
other hand there are particles in the plasma, like LDL,
which contain tocopherols. Therefore, the decreased
LDL cholesterol concentrations of pigs fed lupin protein
isolate compared to those fed casein could also explain
the lower plasma α-tocopherol concentrations.
Another biofunctional molecule which is naturally as-
sociated with the lupin protein isolate is phytic acid.
Phytic acid is suggested to possess also hypocholestero-
lemic properties. Lee and co-workers found that diabetic
KK mice that were fed diets supplemented with 0.5, 1.0,
and 1.5% of phytic acid developed a dose-dependent re-
duction of plasma cholesterol concentrations that was
mainly caused by LDL reduction [41]. Phytic acid also
developed plasma cholesterol-lowering activity in tilapia
[42] and rats fed a high-sucrose diet [43], and increased
faecal cholesterol and bile acid excretion in rats and
mice [44,45]. Koba et al. [46] investigated the influence
of phytate on the cholesterol-lowering effect of soy pro-
tein. Thereby, rats fed a cholesterol-enriched diet with
soy protein and phytate-replenished soy protein showed
significantly lower serum and liver cholesterol concen-
trations than rats fed casein and phytate-depleted soy
protein. Analysis of the lupin protein isolate which we
used for the pig study contained 25 g/kg phytic acid
which corresponds to an additional content of 0.57%
phytic acid in the lupin protein diet. Seeds of legumes
naturally contain relatively high amounts of phytic acid
[47-49], and food technology processes which are used
to isolate proteins from plants normally do not separate
phytic acid from the proteins. Phytate serves as storage
of phosphorus for the plant kernels and has been
regarded as an antinutrient because it inhibits the ab-
sorption of essential trace elements and minerals (for
review see Schlemmer et al. [50]). However, growing
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effects such as antioxidative functions [51,52], and anti-
tumor activity [53]. Data from our in vitro experiment
show that phytate was capable of reducing the cellular
cholesterol-uptake to a similar magnitude as ezetimibe,
a known cholesterol absorption inhibitor [54], whereas
conglutin γ was non-effective. Thus, we assume that
phytate associated with the lupin protein isolate could
have contributed to the observed cholesterol-lowering
effect in the group fed the lupin protein diet. However,
the increased faecal output of calcium and magnesium
and the lower plasma concentrations of both minerals,
therefore, constitute an undesirable side effect of the
cholesterol-lowering activity of lupin protein isolate-
associated phytate.
Conclusions
Collectively, the current data show that lupin protein isolate
compared to casein stimulates faecal output of cholesterol
which is suggested to be responsible for the cholesterol-
lowering effect of lupin proteins. The findings that lupin
protein isolate treated pigs had reduced relative mRNA
concentrations of intestinal NPC1L1 and SR-BI and lower
plasma concentrations of fat-soluble vitamins support the
assumption that lupin proteins negatively affect intestinal
cholesterol absorption. The cholesterol-uptake data pro-
vide evidence that associated phytate could – at least
partly – contribute to the observed cholesterol-lowering
effect of lupin protein isolate.
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